cephalosporin c has been researched along with cefpodoxime proxetil in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (30.77) | 18.7374 |
1990's | 21 (53.85) | 18.2507 |
2000's | 5 (12.82) | 29.6817 |
2010's | 1 (2.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clausen, CR; Del Beccaro, MA; Duncan, NO; Inglis, AF; Mendelman, PM; Richardson, MA; Stull, TL | 1 |
Berk, SL; Caggiano, C; Holtsclaw-Berk, S; Sarubbi, FA; Verghese, A | 1 |
Fukushima, Y; Hori, M; Imai, H; Koizumi, M; Sugita, M; Takahashi, T; Toyonaga, Y; Yamasaki, M | 1 |
Barry, AL; Jones, RN | 1 |
Ando, M; Hashimoto, I; Mizuno, A; Morimoto, K; Nakamura, T; Sakai, K; Shinagawa, N; Ueda, T; Watanabe, S; Yura, J | 1 |
Arai, K; Suzuki, E; Yokota, T | 1 |
Miyahara, T; Nakayama, I; Onodera, S; Saito, A; Sasaki, N; Shiba, K; Shimada, J; Tamura, M; Tomizawa, M | 2 |
Fass, RJ; Helsel, VL | 1 |
Hisazumi, H; Nakajima, K; Ohkawa, M; Oshinoya, Y; Uchibayashi, T | 1 |
Ishii, S; Matsunaga, K; Murohashi, K; Numata, H; Odagiri, S; Suzuki, K; Takahashi, H; Takahashi, K; Yamaki, I | 1 |
Inoue, M; Mitsuhashi, S; Utsui, Y | 1 |
Allen, SD; Ayers, LW; Barry, AL; Fuchs, PC; Jones, RN; Pfaller, M | 1 |
Cohen, R | 1 |
Dajani, AS | 1 |
Edlund, C; Nord, CE; Stark, C | 1 |
Rodriguez, WJ; Wiedermann, BL | 1 |
Savolainen, S; Söderqvist, A; von Sydow, C | 1 |
Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA | 1 |
Kato, H; Numa, F; Sugino, N; Takasugi, N; Tsunaga, N | 1 |
Tagami, H; Terui, T | 1 |
Ishioka, T | 1 |
Ito, K; Ito, M | 1 |
Muranaka, H; Yokoyama, M | 1 |
Imanaka, H; Kitahara, T; Miyata, K; Yoshinaga, M | 1 |
Inoue, T; Ishimaru, T; Kumagai, Y; Misumi, H; Ninomiya, K; Okada, K; Sawae, Y; Shimono, N; Sumida, I; Takaki, K | 1 |
Hashimoto, I; Imaizumi, T; Ishikawa, H | 1 |
Barreto, DG; de la Torre, C; del Castillo, F; MacLoughlin, GJ; Palma, L; Pinetta, EA | 1 |
Alkorta, M; García-Arenzana, JM; Gomariz, M; Iturzaeta, A; Pérez-Trallero, E | 1 |
Blouin, RA; Duchene, P; Hofheinz, W; Laneury, JP; Shedlofsky, S; Stoeckel, K | 1 |
Abdel-Rahman, SM; Borin, MT; Jacobs, RF; Kearns, GL; Wells, TG | 1 |
Chiu, HH; Chiu, TF; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lin, HC; Lu, CY; Tsai, HY | 1 |
Abe, T; Domon, H; Fukuoka, T; Ishii, C; Kakuta, M; Kawada, H; Kitayama, A; Ohya, S; Utsui, Y | 1 |
Abdel-Rahman, SM; Hubbard, AE; Kearns, GL; Maxson, S; Teo, C | 1 |
Flamm, R; Hom, RC; LaFata, JA; le Roux, JG; Palo, WA; van Zyl, L; Volk, RS | 1 |
Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
Fini, A; González, M; Hernández, R; López, MA; Rodríguez, JC; Rodríguez, Z; Tolón, B; Valdés, B; Velez, H | 1 |
Gao, L; Li, Y; Liu, J; Liu, Y; Lü, Y; Xiao, YH | 1 |
Pichichero, ME | 1 |
5 review(s) available for cephalosporin c and cefpodoxime proxetil
Article | Year |
---|---|
Clinical experience with cefpodoxime proxetil in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Prodrugs; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome | 1995 |
Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil.
Topics: Administration, Oral; Adult; Amoxicillin; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Clinical Trials as Topic; Drug Administration Schedule; Europe; Humans; Penicillins; Pharyngitis; Streptococcal Infections; Tonsillitis; Treatment Failure; United States | 1995 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic | 1996 |
Otitis media.
Topics: Age Factors; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Child, Preschool; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media; Otitis Media with Effusion; Otoscopy; Streptococcus pneumoniae; Time Factors; Tympanic Membrane | 2013 |
12 trial(s) available for cephalosporin c and cefpodoxime proxetil
Article | Year |
---|---|
Bacteriology of acute otitis media: a new perspective.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacteriological Techniques; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media; Prodrugs; Punctures; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Tympanic Membrane | 1992 |
[Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 1988 |
[Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia | 1988 |
[Comparative clinical study of CS-807 and cefaclor in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Multicenter Studies as Topic; Respiratory Tract Infections | 1988 |
Clinical experience with cefpodoxime proxetil in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Prodrugs; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome | 1995 |
Treatment of acute maxillary sinusitis--comparing cefpodoxime proxetil with amoxicillin.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Double-Blind Method; Drug Evaluation; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Maxillary Sinusitis; Middle Aged; Penicillins; Pneumococcal Infections; Prodrugs; Streptococcus pneumoniae; Treatment Outcome | 1995 |
Pharmacokinetic study and clinical evaluation of cefpodoxime proxetil in the elderly with impaired renal function.
Topics: Aged; Aged, 80 and over; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Humans; Kidney Diseases; Middle Aged; Prodrugs | 1995 |
Once-a-day therapy of cefpodoxime proxetil for respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prodrugs; Respiratory Tract Infections | 1995 |
Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
Topics: Acute Disease; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Neisseriaceae Infections; Otitis Media; Prodrugs; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Suspensions | 1996 |
Cefpodoxime pharmacokinetics in children: effect of food.
Topics: Area Under Curve; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Eating; Fasting; Female; Humans; Infant; Male; Prodrugs | 1998 |
Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.
Topics: Acute Disease; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Otitis Media; Suspensions | 1998 |
Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Community-Acquired Infections; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; South Africa; Streptococcus pneumoniae; Treatment Outcome; United States | 2002 |
23 other study(ies) available for cephalosporin c and cefpodoxime proxetil
Article | Year |
---|---|
In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against clinical isolates of Branhamella catarrhalis.
Topics: Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections | 1989 |
[Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
Topics: Absorption; Adolescent; Bacteria; Bacterial Infections; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Pneumonia; Tonsillitis | 1989 |
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Drug Evaluation; Drug Stability | 1987 |
Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
Topics: Bacteria; Bacterial Proteins; Carrier Proteins; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Complement System Proteins; Drug Resistance, Microbial; Escherichia coli; Hexosyltransferases; Humans; Macrophages; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Prodrugs; Staphylococcus; Staphylococcus aureus | 1988 |
In vitro activity of U-76,252 (CS-807), a new oral cephalosporin.
Topics: Bacteria; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests | 1988 |
[A clinical evaluation of CS-807 in patients with urinary tract infections].
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Cystitis; Diarrhea; Drug Evaluation; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1988 |
[Clinical studies of cefpodoxime proxetil in respiratory tract infections].
Topics: Administration, Oral; Adult; Aged; Bronchiectasis; Bronchitis; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Drug Evaluation; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Staphylococcal Infections | 1988 |
In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Enterobacteriaceae Infections; Escherichia coli Infections; Hexosyltransferases; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Proteus Infections; Staphylococcal Infections; Streptococcal Infections | 1987 |
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
Topics: Administration, Oral; Cefaclor; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Cephradine; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quality Control | 1988 |
The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.
Topics: Administration, Oral; Adult; Amoxicillin; beta-Lactamases; Cefpodoxime Proxetil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Feces; Female; Humans; Intestines; Male; Middle Aged; Prodrugs | 1994 |
Penetration of cefpodoxime into uterine and vaginal secretions from postpartum women after a single oral dose of cefpodoxime proxetil.
Topics: Administration, Oral; Adult; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Postpartum Period; Prodrugs; Uterus; Vaginal Discharge | 1996 |
Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
Topics: Adolescent; Bacterial Infections; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Prodrugs; Skin Diseases, Infectious | 1995 |
Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
Topics: Bacteria; Bacterial Infections; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Prodrugs; Skin Diseases, Infectious; Soft Tissue Infections | 1995 |
Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
Topics: Adolescent; Bacteria; Bacterial Infections; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Prodrugs | 1995 |
A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
Topics: Adolescent; Bacteria; Bacterial Infections; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Prodrugs | 1995 |
Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prodrugs; Skin Diseases, Infectious | 1995 |
In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae.
Topics: Administration, Oral; Adult; Amoxicillin; Animals; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Cephalosporins; Evaluation Studies as Topic; Female; Humans; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Random Allocation; Serum Bactericidal Test; Streptococcus pneumoniae | 1998 |
Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability.
Topics: Administration, Oral; Adult; Biological Availability; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Stability; Humans; Intestinal Mucosa; Male; Prodrugs | 1998 |
[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Lactams; Male; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Prodrugs; Streptococcus pneumoniae | 1999 |
Cerebrospinal fluid pharmacokinetics of cefpodoxime proxetil in piglets.
Topics: Animals; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Swine | 2000 |
[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Japan; Product Surveillance, Postmarketing; Time Factors | 2002 |
An improved method for preparation of cefpodoxime proxetil.
Topics: Acetates; Acylation; Administration, Oral; Anti-Bacterial Agents; Benzothiazoles; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Chemistry, Pharmaceutical; Drug Compounding; Thiazoles | 2003 |
[Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
Topics: Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae | 2004 |